1. Home
  2. CERO vs MTEX Comparison

CERO vs MTEX Comparison

Compare CERO & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • MTEX
  • Stock Information
  • Founded
  • CERO 2017
  • MTEX 1993
  • Country
  • CERO United States
  • MTEX United States
  • Employees
  • CERO N/A
  • MTEX N/A
  • Industry
  • CERO
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • CERO
  • MTEX Health Care
  • Exchange
  • CERO Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • CERO 12.2M
  • MTEX 14.2M
  • IPO Year
  • CERO N/A
  • MTEX 1999
  • Fundamental
  • Price
  • CERO $0.29
  • MTEX $8.44
  • Analyst Decision
  • CERO
  • MTEX
  • Analyst Count
  • CERO 0
  • MTEX 0
  • Target Price
  • CERO N/A
  • MTEX N/A
  • AVG Volume (30 Days)
  • CERO 174.9M
  • MTEX 2.5K
  • Earning Date
  • CERO 11-25-2024
  • MTEX 11-12-2024
  • Dividend Yield
  • CERO N/A
  • MTEX N/A
  • EPS Growth
  • CERO N/A
  • MTEX N/A
  • EPS
  • CERO N/A
  • MTEX N/A
  • Revenue
  • CERO N/A
  • MTEX $121,552,000.00
  • Revenue This Year
  • CERO N/A
  • MTEX N/A
  • Revenue Next Year
  • CERO N/A
  • MTEX N/A
  • P/E Ratio
  • CERO N/A
  • MTEX N/A
  • Revenue Growth
  • CERO N/A
  • MTEX N/A
  • 52 Week Low
  • CERO $0.06
  • MTEX $6.75
  • 52 Week High
  • CERO $12.80
  • MTEX $10.51
  • Technical
  • Relative Strength Index (RSI)
  • CERO 73.26
  • MTEX 57.26
  • Support Level
  • CERO $0.17
  • MTEX $7.60
  • Resistance Level
  • CERO $0.33
  • MTEX $8.50
  • Average True Range (ATR)
  • CERO 0.04
  • MTEX 0.36
  • MACD
  • CERO 0.02
  • MTEX -0.01
  • Stochastic Oscillator
  • CERO 57.68
  • MTEX 88.29

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: